GSK — GLAXOSMITHKLINE PLC

Ownership history in PARK CIRCLE Co · 47 quarters on record

This page tracks every 13F SEC filing in which PARK CIRCLE Co reported a position in GLAXOSMITHKLINE PLC (GSK). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position

2.03% (2015 Q1)

Avg. % of fund

0.66%

First filed

2014 Q1

Last filed

2025 Q3

Quarters held

47

Quarter	Action	Shares	Change	Chg %	% of Fund	Mkt Value	Price (EOQ)
2025 Q3	REDUCED	480	-320	-40.0%	0.02%	$21K	$42.44
2025 Q2	UNCHANGED	800	—	0%	0.03%	$31K	$37.35
2025 Q1	UNCHANGED	800	—	0%	0.03%	$31K	$37.25
2024 Q4	UNCHANGED	800	—	0%	0.02%	$27K	$32.17

% of Fund (quarterly) GSK price (monthly, adj. close)

Other funds also holding GSK

As of 2025 Q4 — sorted by position size

Eversept Partners, LP 3Y 7Y 6.62% Mondrian Investment Partners LTD 3Y 7Y 4.7% EQUITY INVESTMENT CORP 3Y 7Y 4.07% Callodine Capital Management, LP 3Y 7Y 3.96% Hillman Capital Management, Inc. 3Y 7Y 3.53% KEATING INVESTMENT COUNSELORS INC 3Y 7Y 2.45% MILLER HOWARD INVESTMENTS INC /NY 3Y 7Y 2.43% Clean Yield Group 3Y 7Y 2.2% NIA IMPACT ADVISORS, LLC 3Y 2.08% Altrius Capital Management Inc 3Y 2.05%

← Back to PARK CIRCLE Co Holdings